Skip to main content

Flash glucose monitoring

04-05-2023 | Flash glucose monitoring | News

Reduced acute complications for young people using CGM

Data from the DPV cohort show a reduced risk for severe hypoglycemia and diabetic ketoacidosis among children and young people with type 1 diabetes using continuous glucose monitoring rather than self-monitored blood glucose.

03-07-2023 | Flash glucose monitoring | News

Flash glucose monitoring linked to type 2 diabetes treatment intensification

Use of intermittently scanned continuous glucose monitoring is associated with an increased likelihood for treatment intensification in people with type 2 diabetes, a study shows.

03-01-2023 | Flash glucose monitoring | News

One-off pre-consultation isCGM use helpful in type 2 diabetes

A short period of intermittently scanned continuous glucose monitoring prior to a first endocrinologist consultation can improve glycemic outcomes for people with type 2 diabetes, report the SPOT FIRST study researchers.

02-28-2023 | Flash glucose monitoring | News

Real-world isCGM benefits shown for people with psychosocial diabetes issues

People with high diabetes distress achieve reductions in glycated hemoglobin and the need for emergency care for acute diabetes complications after starting on intermittently scanned continuous glucose monitoring, report researchers.

02-15-2023 | Flash glucose monitoring | News

ALERTT1: rtCGM alarm benefits persist in long term

The benefits of switching from intermittently scanned to real-time continuous glucose monitoring in adults with type 1 diabetes are sustained for at least 2 years, shows the extension of the ALERTT1 study.

Close up oF device for continuous glucose monitoring in blood – CGM

12-15-2022 | Continuous glucose monitoring | News

Eliminating CGM cost barriers reduces disparities in use

Fully subsidizing continuous glucose monitors could overcome disparities in their use by people with diabetes, suggests research conducted in adults enrolled in a US Medicaid program.

09-21-2022 | EASD 2022 | Conference coverage | News

isCGM benefits sustained for at least 2 years

The improved glycemic control gained from use of intermittently scanned continuous glucose monitoring is sustained for at least 2 years in people with type 1 diabetes, show real-world data.

Girl with CGM

09-21-2022 | EASD 2022 | Conference coverage | News

Skin reactions rarely lead to diabetes device discontinuation

Skin reactions to glucose monitors and insulin pumps occur in more than a quarter of users but only occasionally result in device discontinuation, research shows.